Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

NCT05893225 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Primary Progressive Multiple Sclerosis
Secondary-progressive Multiple Sclerosis

Interventions

DRUG: Metformin Hydrochloride 850 mg Oral Tablet
DRUG: Placebo

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]